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A Surgically Treated Case of Chronic Necrotizing Aspergillosis with 
Pleural Invasion
Kyung-Hak  Lee,  M.D.,  Se  Min  Ryu,  M.D.,  Sung-Min  Park,  M.D.,  Hyun  Seok  Park,  M.D., 
Kang  Hoon  Lee,  M.D.,  Seong-Joon  Cho,  M.D.
Aspergillus is a ubiquitous fungus and can cause many levels of disease severity. Chronic necrotizing aspergillosis 
is a rare disease and few cases have been reported in Korea. We experienced a case of pleural aspergillosis 
that was treated successfully with medical and surgical interventions. The 52-year-old man who was diagnosed with 
chronic necrotizing pulmonary aspergillosis underwent surgical treatment including a lobectomy, decortication, and 
myoplasty. The patient was also medically treated with amphotericin B followed by voriconazole. Pleural irrigation 
with amphotericin B was also performed. A multi-dimensional approach should be considered for treating chronic 
necrotizing pulmonary aspergillosis.
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CASE REPORT
A  52-year-old  male  patient  complained  of  pleuritic  pain  of 
the right chest, a persistent cough, and yellowish blood-tinged 
sputum  for  two  months.  He  had  been  diagnosed  with  pulmo-
nary  tuberculosis  and  completely  recovered  after  medical 
treatment;  he  had  no  other  underlying  diseases.  The  patient 
was  a  heavy  daily  drinker  and  had  lost  7  kg  over  the  pre-
vious  six  months  before  admission  to  the  hospital.  His  blood 
pressure  was  125/80  mmHg,  pulse  rate  was  100/min,  and 
body  temperature  was  normal.  Right  breathing  sounds  were 
decreased  with  crackles.  Chest  radiographs  showed  old  tuber-
culosis  scars  and  a  newly  developed  empyema  in  the  right 
lung field (Fig. 1A). Tomography showed several cavitary le-
sions  of  different  sizes,  some  of  which  had  fluid  collection, 
which suggested an infected cyst, an old tuberculosis scar, or 
active  tuberculosis.  Partial  calcification  of  the  pleura,  pleural 
thickening, and pleural effusion were also found (Fig. 2A). A 
yellowish substance was located in the lumen of the right up-
per  lobe  apical  segmental  bronchus  at  bronchoscopy  and  a 
pathologic  examination  of  the  substance  was  performed.  The 
pathologist reported the substance to be pulmonary aspergillo-
sis  (Fig.  3B).
The empyema was drained through a percutaneous catheter 
and  air  leakage  was  observed. A m p h o t e r i c i n  B  ( A M B )  w a s  
injected  after  the  patient  was  diagnosed  with  pulmonary 
aspergillosis.  After  the  administration  of  AMB,  a  fever  that 
the  patient  had  since  the  second  day  of  admission  subsided, A Surgically Treated Case of Chronic Necrotizing Aspergillosis with Pleural Invasion
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Fig. 1. Chest radiograph before operation showed empyema in the right pleural cavity (A), Postoperative chest radiograph (B), and recent 
chest radiograph (C).
Fig. 2. (A) Tomography before the 
operation shows cavitary lesions and 
pleural lesions in the right pleural 
cavity. (B) Recent tomography shows 
a small cavity and no pleural effu-
sion.
the  white  blood  cell  count  decreased  from  12,900/mL  to 
7,900/mL,  and  C-reactive  protein  decreased  from  22.9  mg/dL 
t o  4 . 4  m g / d L .  O n  t h e  f o u r t e e n t h  d a y  o f  a d m i s s i o n ,  a  3  
French  Fogarty  catheter  was  introduced  to  the  right  upper 
lobe  apical  segmental  bronchus  and  the  bronchus  was  obli-
terated  with  the  balloon  under  general  anesthesia.  After  the 
obliteration  of  the  bronchus,  the  air  leakage  decreased 
dramatically. The location of the fistula was confirmed with a 
fistulography by using a percutaneous catheter and a blockage 
test  with  the  balloon  of  the  Fogarty  catheter.  We  attempted Kyung-Hak Lee, et al
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Fig. 3. (A) Bronchoscope showed a 
mass of Aspergillus in the right up-
per lobe apical segmental bronchus. 
(B) Methenamine silver stain of 
Aspergillus, ×400.
fistula  occlusion  with  BioGlue  and  a  coil  while  the  bronchus 
was blocked with the Fogarty catheter balloon, but the occlu-
sion  of  the  fistula  failed  due  to  the  existence  of  multiple 
broncho-pleural  fistulae.
Nutritional  support  and  AMB  injections  continued  for  1 
month and during that period the patient gained 3 kg and his 
nutritional state improved. Pleural cavity irrigation with AMB 
mixed  with  1  L  of  5%  dextrose  was  performed  for  5  hours 
daily (the total amount of AMB was 1,300 mg for irrigation). 
However,  the  patient  developed  an  intermittent  fever  again. 
Since  the  persistent  air  leakage  and  drainage  of  turbid  fluid 
through the percutaneous catheter lasted for 1 month, a lobec-
tomy and pleural decortication was performed. No air leakage 
was  observed  and  the  fever  subsided  after  the  operation.  A 
pathologic  exam  showed  Aspergillus  invading  the  pleura.
Two  weeks  after  the  operation,  the  patient  developed  a  fe-
ver,  leukocytosis,  and  air  leakage.  Computed  tomography 
showed  an  air  space  at  the  posterior  pleural  cavity.  Irrigation 
with 12,000 mL of normal saline was performed in the oper-
ating  room  and  the  absence  of  air  leakage  through  the  bron-
c h u s  s t u m p  w a s  c o n f i r m e d .  H o wever,  air  leakage  was  ob-
served from the surface of the lung. The antifungal agent was 
converted  to  an  oral  voriconazole,  and  the  patient  was  dis-
c h a r g e d  w i t h  o n e  c h e s t  t u b e  t o  w h i c h  a  H e i m l i c h  v a l v e  w a s  
connected since there was air leakage and a small amount of 
a  yellowish  substance  drained  through  the  chest  tube.
The  patient  developed  massive  bleeding  (1,000  mL) 
through  the  chest  tube  5  months  after  being  discharged.  The 
intra-operative  finding  was  that  the  bleeding  originated  from 
the  chest tube tract. Bleeding  control and  myoplasty with the 
pectoralis  major  muscle  and  latissimus  dorsi  were  performed 
to  fill  the  dead  space  of  the  pleural  cavity.  There  had  been 
no  dead  space  observed  immediately  after  the  operation,  but 
dead  space  in  the  pleural  cavity  had  eventually  formed. 
However,  the  dead  space  gave  rise  to  no  clinical  problems. 
The  patient  was  discharged  without  the  chest  tube  and  no 
complications  have  arisen  for  15  months  post-retreatment.
DISCUSSION
Aspergillus  is  a  ubiquitous  fungus;  about  200  species  have 
been  reported,  but  only  a  few  are  pathogenic.
Aspergillosis  is  classified  into  invasive  aspergillosis,  sapro-
phytic  aspergillosis,  and  the  allergic  form  of  aspergillosis. 
Invasive aspergillosis is a hematologic systemic infection or a 
direct  infection  from  a  former  infection  route.  Although 
Walsh  et  al.  [1]  classified  chronic  necrotizing  aspergillosis 
( C N A )  w i t h i n  i n v a s i v e  a s p e r g i l l o s i s ,  C N A  i s  a  d i f f e r e n t  d i s -
ease entity than invasive aspergillosis or the saprophytic form 
of  aspergillosis  [2].
Aspergillus  does  not  usually  cause  life-threatening  medical 
problems  in  immunocompetent  patients.  With  HIV  infection, 
chemotherapy  for  malignant  cancer,  hematopoietic  stem  cell 
transplantation,  or  organ  transplantation,  systemic  infection  of 
Aspergillus  causes  problems  more  frequently. 
CNA  is  also  called  semi-invasive  aspergillosis  or  subacute 
invasive  aspergillosis;  it  causes  progressive  lung  and  pleural 
injury without prominent symptoms, and usually the pathogen 
is  Aspergillus  fumigatus.  In  particular,  CNA  that  invades  the 
pleura  is  rarely  reported.  CNA  progresses  for  several  months A Surgically Treated Case of Chronic Necrotizing Aspergillosis with Pleural Invasion
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and  does  not  invade  the  blood  vessels  or  other  organs.  CNA 
is  characterized as  a local invasion.  Th ese ar e the diff er ences 
between  CNA  and  invasive  aspergillosis.  Unlike  saprophytic 
aspergillosis,  CNA  does  not  require  prior  lung  injury  [2].
As  we  reviewed  in  this  case,  the  immunosuppressive  mid-
dle-aged  or  elderly  patients  are  usually  vulnerable  to  CNA 
and  complain  of  fever,  cough,  sputum,  and  weight  loss.  The 
standard diagnostic methods are a microscopic examination or 
culture,  a  pathologic  confirmation  of  Aspergillus  from  the 
sample  that  is  acquired  from  bronchoalveolar  lavage,  or  a 
video  assisted  thoracoscopic  surgery  biopsy.  Galactomannan 
EIA  and  (1->3)-beta-D-glucans  serum  tests  are  of  diagnostic 
help  to  some  extent  [1].
The  oral  form  of  itraconazol e  i s  r e c o m m e n d e d  a n d  v o r -
iconazole  is  suspected  to  be  just  as  effective  as  itraconazole 
for  CNA  [1],  but  voriconazole  is  preferred  due  to  the  ex-
cellent  coverage  of  a  wide  spectrum  of  fungus  types  [3].
Hargis et al. [4] performed an intracavitary instillation with 
AMB  successfully  and  reported  a  decrease  in  the  size  of  the 
cavity.  When  a  patient  is  tolerant  of  pleural  irrigation,  treat-
ment  with  AMB  can  be  attempted.
A l t h o u g h  s u r g i c a l  t r e a t m e n t  o f  C N A  i s  n o t  u s u a l l y  r e c o m -
mended  due  to  the  risk  of  the  surgery  itself,  persistently 
symptomatic  patients  or  complications  such  as  hemoptysis  or 
frequent  secondary  infection  through  broncho-pleural  fistula 
are  indications  for  surgical  intervention.  Our  patient  showed 
empyema,  bronchopleural  fistula  (BPF),  and  prolonged  respi-
ratory  symptoms;  aggressive  surgical  intervention  was  nece-
ssary. If a  lung  lesion adjacent  to a  large  vessel and  invaded 
pleura is observed, then the treatment of choice is a resection 
of  the  lung  lesion  and  decortications  [1].
Ahn  et  al.  [5]  recommended  a  myoplasty  with  the  inter-
costals, pectoralis major, latissimus dorsi, and omentoplasty to 
prevent BPF and dead space of the pleural cavity after a lung 
resection.
Although  it  was  subclinical,  our  patient  showed  a  partial 
cavitary  recurrence  after  the  obliteration  of  the  cavity.  We 
suspect  that  muscle  atrophy  and  migration  were  the  main 
causes. Grima et al. [6] suggested that a limited thoracoplasty 
combined  with  a  myoplasty  and  a  cavernostomy  resulted  in 
immediate  good  results  and the prevention of  late  recurrence.
CNA  is  a  rare  disease  but  can  cause  many  complications. 
Surgical  treatment  can  be  a  good  choice  for  treatment  of 
CNA.  In  addition,  we  need  to  consider  multiple  treatment 
modalities  including  medical  and  surgical  options,  and  local 
irrigation  to  treat  CNA  with  pleural  invasion.
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